Market closed

DexCom/$DXCM

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About DexCom

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Ticker

$DXCM
Sector
Health Care
Trading on
NASDAQ

Industry

Health Care Equipment & Supplies
Headquarters
San Diego, United States

Employees

9,550
Website
www.dexcom.com

DexCom Metrics

BasicAdvanced
$31B
47.88
$1.67
1.18
-

$31B

1.18

$142.00

$62.34

3.1M

2.458

2.033

129.808

130.935

33.05%

6.06%

32.06%

47.881

7.914

15.76

16.87

58.488

16.19%

83.21%

19.46%

6.17%

What the Analysts think about DexCom

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for DexCom stock.

DexCom Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

DexCom Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

DexCom News

AllArticlesVideos
Dexcom forecasts 2025 revenue mostly in-line with expectations

Dexcom forecasts 2025 revenue mostly in-line with expectations

Reuters·2 days ago
Abbott and DexCom settle glucose monitor patent disputes

Abbott and DexCom settle glucose monitor patent disputes

Reuters·3 weeks ago
Dexcom Launches the First Generative AI Platform in Glucose Biosensing

Dexcom Launches the First Generative AI Platform in Glucose Biosensing

Business Wire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $DXCM

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for DexCom stock?

DexCom (DXCM) has a market cap of $31B as of January 15, 2025.

What is the P/E ratio for DexCom stock?

The price to earnings (P/E) ratio for DexCom (DXCM) stock is 47.88 as of January 15, 2025.

Does DexCom stock pay dividends?

No, DexCom (DXCM) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next DexCom dividend payment date?

DexCom (DXCM) stock does not pay dividends to its shareholders.

What is the beta indicator for DexCom?

DexCom (DXCM) has a beta rating of 1.18. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.